Literature DB >> 25391294

Sumoylation of p35 modulates p35/cyclin-dependent kinase (Cdk) 5 complex activity.

Anja Büchner1, Petranka Krumova, Sundar Ganesan, Mathias Bähr, Katrin Eckermann, Jochen H Weishaupt.   

Abstract

Cyclin-dependent kinase (Cdk) 5 is critical for central nervous system development and neuron-specific functions including neurite outgrowth as well as synaptic function and plasticity. Cdk5 activity requires association with one of the two regulatory subunits, called p35 and p39. p35 redistribution as well as misregulation of Cdk5 activity is followed by cell death in several models of neurodegeneration. Posttranslational protein modification by small ubiquitin-related modifier (SUMO) proteins (sumoylation) has emerged as key regulator of protein targeting and protein/protein interaction. Under cell-free in vitro conditions, we found p35 covalently modified by SUMO1. Using both biochemical and FRET-/FLIM-based approaches, we demonstrated that SUMO2 is robustly conjugated to p35 in cells and identified the two major SUMO acceptor lysines in p35, K246 and K290. Furthermore, different degrees of oxidative stress resulted in differential p35 sumoylation, linking oxidative stress that is encountered in neurodegenerative diseases to the altered activity of Cdk5. Functionally, sumoylation of p35 increased the activity of the p35/Cdk5 complex. We thus identified a novel neuronal SUMO target and show that sumoylation is a likely candidate mechanism for the rapid modulation of p35/Cdk5 activity in physiological situations as well as in disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25391294     DOI: 10.1007/s12017-014-8336-4

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  56 in total

1.  Cyclin-dependent kinase 5 (Cdk5) activation domain of neuronal Cdk5 activator. Evidence of the existence of cyclin fold in neuronal Cdk5a activator.

Authors:  D Tang; A C Chun; M Zhang; J H Wang
Journal:  J Biol Chem       Date:  1997-05-09       Impact factor: 5.157

Review 2.  Modification in reverse: the SUMO proteases.

Authors:  Debaditya Mukhopadhyay; Mary Dasso
Journal:  Trends Biochem Sci       Date:  2007-05-17       Impact factor: 13.807

3.  Characterization of an improved donor fluorescent protein for Forster resonance energy transfer microscopy.

Authors:  Richard N Day; Cynthia F Booker; Ammasi Periasamy
Journal:  J Biomed Opt       Date:  2008 May-Jun       Impact factor: 3.170

4.  Enhanced SUMOylation of proteins containing a SUMO-interacting motif by SUMO-Ubc9 fusion.

Authors:  Eui Tae Kim; Kyeong Kyu Kim; Mike J Matunis; Jin-Hyun Ahn
Journal:  Biochem Biophys Res Commun       Date:  2009-07-25       Impact factor: 3.575

5.  An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator.

Authors:  D Tang; J Yeung; K Y Lee; M Matsushita; H Matsui; K Tomizawa; O Hatase; J H Wang
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

6.  Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9.

Authors:  M H Tatham; E Jaffray; O A Vaughan; J M Desterro; C H Botting; J H Naismith; R T Hay
Journal:  J Biol Chem       Date:  2001-07-12       Impact factor: 5.157

7.  Structure and regulation of the CDK5-p25(nck5a) complex.

Authors:  C Tarricone; R Dhavan; J Peng; L B Areces; L H Tsai; A Musacchio
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

Review 8.  Inflammation in neurodegenerative diseases--an update.

Authors:  Sandra Amor; Laura A N Peferoen; Daphne Y S Vogel; Marjolein Breur; Paul van der Valk; David Baker; Johannes M van Noort
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

9.  Cdk5/p35 phosphorylates mSds3 and regulates mSds3-mediated repression of transcription.

Authors:  Zhen Li; Gregory David; Kwok-Wang Hung; Ronald A DePinho; Amy K Y Fu; Nancy Y Ip
Journal:  J Biol Chem       Date:  2004-10-15       Impact factor: 5.157

Review 10.  Sumoylation in neurodegenerative diseases.

Authors:  Petranka Krumova; Jochen H Weishaupt
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

View more
  6 in total

1.  Characterization of the CDK5 gene in Apis cerana cerana (AccCDK5) and a preliminary identification of its activator gene, AccCDK5r1.

Authors:  Guangdong Zhao; Chen Wang; Hongfang Wang; Lijun Gao; Zhenguo Liu; Baohua Xu; Xingqi Guo
Journal:  Cell Stress Chaperones       Date:  2017-07-03       Impact factor: 3.667

Review 2.  The Role of Cdk5 in Alzheimer's Disease.

Authors:  Shu-Lei Liu; Chong Wang; Teng Jiang; Lan Tan; Ang Xing; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-07-31       Impact factor: 5.590

3.  SUMOylation of synapsin Ia maintains synaptic vesicle availability and is reduced in an autism mutation.

Authors:  Leo T-H Tang; Tim J Craig; Jeremy M Henley
Journal:  Nat Commun       Date:  2015-07-15       Impact factor: 14.919

Review 4.  Biological functions of CDK5 and potential CDK5 targeted clinical treatments.

Authors:  Alison Shupp; Mathew C Casimiro; Richard G Pestell
Journal:  Oncotarget       Date:  2017-03-07

Review 5.  Post-translational modifications of CDK5 and their biological roles in cancer.

Authors:  Gui-Bin Gao; Yue Sun; Run-Dong Fang; Ying Wang; Yang Wang; Qing-Yu He
Journal:  Mol Biomed       Date:  2021-07-20

Review 6.  Cdk5 links with DNA damage response and cancer.

Authors:  Wan Liu; Jun Li; Yu-Shu Song; Yue Li; Yu-Hong Jia; Hai-Dong Zhao
Journal:  Mol Cancer       Date:  2017-03-14       Impact factor: 27.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.